RJA
LIAN

Raymond James & Associates’s LianBio American Depositary Shares LIAN Stock Holding History

Raymond James & Associates’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,650
Closed -$21K – 4100
2022
Q3 		$21K Hold
10,650
– – ﹤0.01% 3794
2022
Q2 		$23K Buy
+10,650
New +$36.2K ﹤0.01% 3863

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Raymond James & Associates's LIAN Position: Q4 2022 in Review

Raymond James & Associates sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 10,650 shares — an estimated $21K sold.

Raymond James & Associates first reported a position in LIAN in Q2 2022 and held it in 2 quarters. The position peaked at $23K in Q2 2022. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • Raymond James & Associates reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 10,650 LianBio American Depositary Shares shares in Q4 2022, an estimated $21K.
  • Raymond James & Associates first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 2 quarters.
  • Raymond James & Associates's LianBio American Depositary Shares position peaked at $23K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.